These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24965104)

  • 21. [Efficacy of individualized sublingual immunotherapy with dermatophagoides farinae drops on patients with allergic rhinitis of different age groups].
    Liu J; Hu X; Fu S; Wu C; Chen H; Zhang M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(5):289-92. PubMed ID: 25185278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublingual immunotherapy and omalizumab cured allergic chronic rhinosinusitis and asthma: coincidence or synergistic effect?
    Konstantinou GN; Kaitalidou E; Skoulikaris N
    Ann Allergy Asthma Immunol; 2019 Nov; 123(5):440-443. PubMed ID: 31445089
    [No Abstract]   [Full Text] [Related]  

  • 23. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study.
    Di Rienzo V; Cadario G; Grieco T; Galluccio AG; Caffarelli C; Liotta G; Pecora S; Burastero SE
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):671-673.e1. PubMed ID: 25304342
    [No Abstract]   [Full Text] [Related]  

  • 24. [SUBLINGUAL IMMUNOTHERAPY FOR MITE ALLERGIC RHINITIS].
    Okamoto Y
    Arerugi; 2016; 65(9):1187-1191. PubMed ID: 27885202
    [No Abstract]   [Full Text] [Related]  

  • 25. Allergy and immunology.
    Assa'ad A
    Pediatr Ann; 2014 Aug; 43(8):312. PubMed ID: 25102485
    [No Abstract]   [Full Text] [Related]  

  • 26. Is Sublingual Immunotherapy an Effective Therapy for Allergic Rhinitis?
    Ahmed OG; Lane AP
    Laryngoscope; 2020 Oct; 130(10):2301-2302. PubMed ID: 32068887
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety, tolerability and clinical efficacy of ultra-rush sublingual immunotherapy among patients suffering from allergic rhinitis.
    Balaji R; Parasuramalu BG; Chandregowda BV; Gangaboraiah
    Allergol Immunopathol (Madr); 2014; 42(3):216-23. PubMed ID: 23481554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue loss with subcutaneous immunotherapy--Nicolau syndrome.
    Tierce ML; Schultz SM; Lanier BQ
    J Allergy Clin Immunol Pract; 2016; 4(1):154-5. PubMed ID: 26362220
    [No Abstract]   [Full Text] [Related]  

  • 29. Patients' perception in assessing allergen immunotherapy.
    Ciprandi G; Incorvaia C; Dell'Albani I; Ricciardi L; Puccinelli P; Frati F;
    Allergol Immunopathol (Madr); 2014; 42(6):629-31. PubMed ID: 24269181
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.
    Martín-Muñoz MF; Pineda F; Muiños T; Fontan M; Nevot S; Bosque M; Jurado Palomo J; Torredemer A; Valdesoiro L; Martinez Cañavate AM; Pedemonte Marco C;
    Allergol Immunopathol (Madr); 2013; 41(1):4-10. PubMed ID: 22321665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.
    Spertini F; Perrin Y; Audran R; Pellaton C; Boudousquié C; Barbier N; Thierry AC; Charlon V; Reymond C
    J Allergy Clin Immunol; 2014 Jul; 134(1):239-240.e13. PubMed ID: 24797422
    [No Abstract]   [Full Text] [Related]  

  • 32. The year in review: The best of 2016 in the Annals.
    Marshall GD; Bielory L; Walter Canonica G; Desai M; Ellis AK; Hsieh FH; Grayson MH; Greenhawt M; Lieberman JA; Montanaro A; Oppenheimer J
    Ann Allergy Asthma Immunol; 2017 Jan; 118(1):4-9. PubMed ID: 28007087
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials.
    Tao L; Shi B; Shi G; Wan H
    Clin Respir J; 2014 Apr; 8(2):192-205. PubMed ID: 24118881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to sublingual immunotherapy in preschool children.
    Pajno GB; Caminiti L; Crisafulli G; Barberi S; Landi M; Aversa T; Valenzise M; Passalacqua G
    Pediatr Allergy Immunol; 2012 Nov; 23(7):688-9. PubMed ID: 22985448
    [No Abstract]   [Full Text] [Related]  

  • 35. Sublingual immunotherapy: factors influencing adherence.
    Bernaola G; Corzo JL; Domínguez-Ortega J; Lucas C; Ojeda I; Torres-Borrego J;
    J Investig Allergol Clin Immunol; 2012; 22(6):458-9. PubMed ID: 23101200
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of dendritic cells on allergic rhinitis in sublingual therapy].
    Liu S; Ge R; Yu S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 28(14):1089-92. PubMed ID: 25330657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis].
    Li G; Zhu C; Chen J; Yu S; Lin J; Wang B; Ye B; Zhang S; Zhao X; Zhang T; He Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Sep; 27(17):935-7. PubMed ID: 24358793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunotherapy for allergic rhinitis].
    Yuta A
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Feb; 118(2):152-5. PubMed ID: 26506624
    [No Abstract]   [Full Text] [Related]  

  • 39. Sublingual immunotherapy: what we can learn from the European experience.
    Linkov G; Toskala E
    Curr Opin Otolaryngol Head Neck Surg; 2014 Jun; 22(3):208-10. PubMed ID: 24801802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific immunotherapy for allergic rhinitis in children.
    Wang C; Zhang L
    Curr Opin Otolaryngol Head Neck Surg; 2014 Dec; 22(6):487-94. PubMed ID: 25207858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.